ARCUTIS BIOTHERAPEUTICS INC
ARQT·03969K108·US·Common Stock·Healthcare - Biotechnology-Activist
ARQT (ARCUTIS BIOTHERAPEUTICS INC) is held by 146 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($216.8M), STATE STREET CORP ($148.3M), Polar Capital Holdings Plc ($133.5M). Net institutional sentiment: Mixed. In Q1 2026, 1 member of Congress and 81 funds bought ARQT.
146
Holders
(11 Elite)
$2.1B
Total Value
55% (146)
Consensus
81 buying - 65 selling
13F: Insider & Congress:
Who's Trading
InsiderWTWatanabe ToddSell $75KMay 4, 2026
InsiderMMMatsuda MasaruSell $172KMay 4, 2026
InsiderMMMatsuda MasaruSell $21KMay 4, 2026
InsiderBPBurnett PatrickSell $16KMay 4, 2026
Showing 1-20 of 155
1 / 8
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer